A newly proposed model suggests cancer cells may resist treatment not just through genetic mutations, but by dynamically ...

Asgard’s immunotherapy, AT-108, induces systemic, dose-dependent efficacy with broad tumor activity in preclinical studies ...

The field of plant epigenetics is increasingly recognized for its crucial role in mediating plant responses to diverse environmental stressors intensified ...

A novel strategy that combines computational and experimental approaches has allowed researchers at Baylor College of Medicine and the Duncan Neurological Research Institute (Duncan NRI) at Texas ...

Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat. Even with effective ...

New studies by two major La Jolla medical research institutions explore aging and its effects on the brain, albeit with different focuses. In an effort to better understand the impact of aging on ...

Scientists discovered that fatty liver disease alters protein production primarily through translational control rather than ...

“The current study investigates the effect of stevia and sucralose on a wide range of risk markers in a multi-generation study in mice. With a large number of endpoints, there is always the risk of ...

Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard’s lead asset AT-108 into Phase 1 ...

Following Flagship's origination of generative protein and mRNA platforms, Serif is pioneering Modified DNA medicines to program the foundational information layer of biology Serif to present data at ...

Using single-nucleus RNA sequencing, the authors map transcriptional changes in the rat ventral tegmental area following chronic inflammatory pain and acute morphine exposure. Notably, their ...

A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...